Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lowsky

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|April 25, 2024
Management of post-autologous transplant relapse in patients with T-cell lymphomasOlivier Veilleux, Francisco Socola, Sally Arai, et al.
Blood|May 9, 2009
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donorsHolbrook E Kohrt, Brit B Turnbull, Kartoosh Heydari, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 19, 2025
Combined nonmyeloablative total lymphoid irradiation and low-dose total body irradiation enhances donor chimerism and leads to islet allograft acceptanceShiva Pathak, Bettina P Iliopoulou, Blake Mosher, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
The New England Journal of Medicine|September 30, 2005
Protective conditioning for acute graft-versus-host diseaseRobert Lowsky, Tsuyoshi Takahashi, Yin Ping Liu, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
Blood|May 8, 2012
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceSally Arai, Bita Sahaf, Balasubramanian Narasimhan, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|April 25, 2024
Management of post-autologous transplant relapse in patients with T-cell lymphomasOlivier Veilleux, Francisco Socola, Sally Arai, et al.
Blood|May 9, 2009
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donorsHolbrook E Kohrt, Brit B Turnbull, Kartoosh Heydari, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 19, 2025
Combined nonmyeloablative total lymphoid irradiation and low-dose total body irradiation enhances donor chimerism and leads to islet allograft acceptanceShiva Pathak, Bettina P Iliopoulou, Blake Mosher, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
The New England Journal of Medicine|September 30, 2005
Protective conditioning for acute graft-versus-host diseaseRobert Lowsky, Tsuyoshi Takahashi, Yin Ping Liu, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
Blood|May 8, 2012
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceSally Arai, Bita Sahaf, Balasubramanian Narasimhan, et al.
Pageof 7